Catalyst Wire Dossier Catalyst Wire Dossier

HBV-MPL vaccine formulations

HBV vaccine with MPL adjuvant · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HBV-MPL vaccine formulations, covering 2008-06-17 to 2008-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y [Phase 2]

See pricing